Titre : Désalkylation

Désalkylation : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Désalkylation : Questions médicales les plus fréquentes", "headline": "Désalkylation : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Désalkylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-28", "dateModified": "2025-02-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Désalkylation" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Métabolisme", "url": "https://questionsmedicales.fr/mesh/D008660", "about": { "@type": "MedicalCondition", "name": "Métabolisme", "code": { "@type": "MedicalCode", "code": "D008660", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Déméthylation", "alternateName": "Demethylation", "url": "https://questionsmedicales.fr/mesh/D000073398", "about": { "@type": "MedicalCondition", "name": "Déméthylation", "code": { "@type": "MedicalCode", "code": "D000073398", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03.219.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Déméthylation de l'ADN", "alternateName": "DNA Demethylation", "url": "https://questionsmedicales.fr/mesh/D000073399", "about": { "@type": "MedicalCondition", "name": "Déméthylation de l'ADN", "code": { "@type": "MedicalCode", "code": "D000073399", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G03.219.500.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Désalkylation", "alternateName": "Dealkylation", "code": { "@type": "MedicalCode", "code": "D003640", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael R Baldwin", "url": "https://questionsmedicales.fr/author/Michael%20R%20Baldwin", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600." } }, { "@type": "Person", "name": "Suzanne J Admiraal", "url": "https://questionsmedicales.fr/author/Suzanne%20J%20Admiraal", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600." } }, { "@type": "Person", "name": "Patrick J O'Brien", "url": "https://questionsmedicales.fr/author/Patrick%20J%20O%27Brien", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600. Electronic address: pjobrien@umich.edu." } }, { "@type": "Person", "name": "Yusuke Suzuki", "url": "https://questionsmedicales.fr/author/Yusuke%20Suzuki", "affiliation": { "@type": "Organization", "name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan." } }, { "@type": "Person", "name": "Takafumi Naito", "url": "https://questionsmedicales.fr/author/Takafumi%20Naito", "affiliation": { "@type": "Organization", "name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan. naitou@shinshu-u.ac.jp." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.", "datePublished": "2023-05-22", "url": "https://questionsmedicales.fr/article/37217960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07352-7" } }, { "@type": "ScholarlyArticle", "name": "Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39375728", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-024-08495-x" } }, { "@type": "ScholarlyArticle", "name": "Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36566693", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuchi.2022.101403" } }, { "@type": "ScholarlyArticle", "name": "Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study.", "datePublished": "2023-01-22", "url": "https://questionsmedicales.fr/article/36606735", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cpt.2841" } }, { "@type": "ScholarlyArticle", "name": "Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35804404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06365-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Métabolisme", "item": "https://questionsmedicales.fr/mesh/D008660" }, { "@type": "ListItem", "position": 3, "name": "Désalkylation", "item": "https://questionsmedicales.fr/mesh/D003640" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Désalkylation - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Désalkylation", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Désalkylation", "description": "Comment diagnostiquer une désalkylation ?\nQuels tests sont utilisés pour la désalkylation ?\nQuels signes indiquent une désalkylation ?\nLa désalkylation est-elle détectable par imagerie ?\nQuels marqueurs sont associés à la désalkylation ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Désalkylation", "description": "Quels symptômes sont liés à la désalkylation ?\nLa désalkylation provoque-t-elle des effets neurologiques ?\nY a-t-il des symptômes cutanés associés ?\nLa désalkylation affecte-t-elle le foie ?\nQuels signes de toxicité sont observés ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Désalkylation", "description": "Comment prévenir la désalkylation ?\nLes contrôles médicaux aident-ils à prévenir la désalkylation ?\nL'éducation des patients est-elle importante ?\nLes changements de mode de vie aident-ils ?\nLes professionnels de santé jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Désalkylation", "description": "Quel traitement pour une désalkylation toxique ?\nLes médicaments peuvent-ils aider à la désalkylation ?\nComment gérer les symptômes de désalkylation ?\nY a-t-il des traitements préventifs ?\nLa désalkylation nécessite-t-elle une hospitalisation ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Désalkylation", "description": "Quelles complications peuvent survenir ?\nLa désalkylation peut-elle entraîner des maladies chroniques ?\nY a-t-il des risques de surdosage ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Désalkylation", "description": "Quels sont les facteurs de risque de désalkylation ?\nL'âge influence-t-il le risque de désalkylation ?\nLes habitudes alimentaires affectent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies préexistantes influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une désalkylation ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests biochimiques et des analyses de sang pour évaluer les métabolites." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la désalkylation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de toxicologie et des analyses enzymatiques sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une désalkylation ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes cliniques comme des anomalies hépatiques peuvent indiquer une désalkylation." } }, { "@type": "Question", "name": "La désalkylation est-elle détectable par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, la désalkylation est généralement évaluée par des tests biochimiques, pas par imagerie." } }, { "@type": "Question", "name": "Quels marqueurs sont associés à la désalkylation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs comme les enzymes hépatiques peuvent être augmentés lors de la désalkylation." } }, { "@type": "Question", "name": "Quels symptômes sont liés à la désalkylation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des nausées, des vomissements et des douleurs abdominales." } }, { "@type": "Question", "name": "La désalkylation provoque-t-elle des effets neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets neurologiques comme des vertiges peuvent survenir en cas de désalkylation." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent apparaître en raison de réactions aux métabolites de désalkylation." } }, { "@type": "Question", "name": "La désalkylation affecte-t-elle le foie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des anomalies hépatiques et une hépatotoxicité." } }, { "@type": "Question", "name": "Quels signes de toxicité sont observés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de toxicité incluent fatigue, confusion et jaunisse dans les cas graves." } }, { "@type": "Question", "name": "Comment prévenir la désalkylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des substances chimiques et suivre les prescriptions médicales aide." } }, { "@type": "Question", "name": "Les contrôles médicaux aident-ils à prévenir la désalkylation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers peuvent détecter des problèmes avant qu'ils ne deviennent graves." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients sur les risques des médicaments et des toxines est crucial." } }, { "@type": "Question", "name": "Les changements de mode de vie aident-ils ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain peut réduire le risque de désalkylation et de complications." } }, { "@type": "Question", "name": "Les professionnels de santé jouent-ils un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les professionnels de santé doivent surveiller les interactions médicamenteuses et les risques." } }, { "@type": "Question", "name": "Quel traitement pour une désalkylation toxique ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des soins de soutien et des antidotes spécifiques selon le toxique." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la désalkylation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent faciliter le métabolisme et l'élimination des toxines." } }, { "@type": "Question", "name": "Comment gérer les symptômes de désalkylation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des symptômes inclut des antiémétiques et des analgésiques pour le confort." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les substances toxiques et surveiller les médicaments peut prévenir la désalkylation." } }, { "@type": "Question", "name": "La désalkylation nécessite-t-elle une hospitalisation ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend de la gravité des symptômes et de l'exposition aux toxines, parfois nécessaire." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions hépatiques, des troubles neurologiques et des réactions allergiques." } }, { "@type": "Question", "name": "La désalkylation peut-elle entraîner des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une désalkylation sévère peut contribuer à des maladies chroniques comme la cirrhose." } }, { "@type": "Question", "name": "Y a-t-il des risques de surdosage ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un surdosage de substances pouvant subir désalkylation peut être fatal." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance clinique et les tests de laboratoire réguliers sont essentiels pour détecter les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de désalkylation ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'exposition à des toxines, l'usage de certains médicaments et des antécédents hépatiques." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de désalkylation ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru en raison d'une fonction hépatique diminuée." } }, { "@type": "Question", "name": "Les habitudes alimentaires affectent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en toxines ou en médicaments peut augmenter le risque de désalkylation." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut augmenter le risque de désalkylation en raison de l'exposition à des substances nocives." } }, { "@type": "Question", "name": "Les maladies préexistantes influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'hépatite ou la cirrhose augmentent le risque de désalkylation." } } ] } ] }

Sources (10000 au total)

A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.

Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rat... A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be... This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI coun... ClinicalTrials.gov NCT04673565 . Registered on 17 December 2020....

Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).

Depression is a leading cause of disability worldwide, and treatments could be more effective. Identifying methods to improve treatment success has the potential to reduce disease burden dramatically.... The CBT + trial will be a parallel-arm randomized controlled trial that will recruit 40 adult participants with DSM-5 diagnosed depression (verified with clinical interview) via referrals, mass emails... The novel approach of priming CBT with moderate-intensity aerobic exercise evaluated in a randomized controlled trial (CBT + trial) has the potential to demonstrate the usefulness of exercise as an au... ClinicalTrials.gov NCT06001346 . Registered on August 21, 2023....

Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.

To better understand the explanatory-pragmatic distinction in the design and interpretation of randomized controlled trials (RCTs).... We review the explanatory-pragmatic distinction in clinical trial design. We use the PRECIS-2 tool to evaluate the trial design of selected RCTs on percutaneous vertebroplasty for osteoporotic vertebr... The selection of criteria and the scoring of multiple PRECIS domains were subjective and thus debatable. The pragmascope patterns of various vertebroplasty trials were heterogeneous. Many trials had b... The results of a trial cannot be interpreted without understanding the various design choices made along the explanatory-pragmatic spectrum....

Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.

Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations presenting as clusters of cysts filled with lymph fluid or blood. Even small well-limited lesions can be ... This is a randomized, multicentric study using an individually randomized stepped-wedge design over 24 weeks to evaluate topical application of a 1 mg/mL sirolimus solution once daily, on LMLM, versus... Given the disappointing state of current treatment options in LMLMs, topical sirolimus could become firstline therapy in treating LMLMs if its efficacy and safety were to be demonstrated.... ClinicalTrials.gov NCT04128722 . Registered on 24 September 2019. EudraCT: EUCTR2019-001530-33-FR Sponsor (University Hospital Center of Tours - CHRU Tours): DR190041-TOPGUN French regulatory authorit...

Ayurveda Management of Allergic Rhinitis: Protocol for a Randomized Controlled Trial.

Allergic rhinitis (AR) is the inflammation of the membranes lining the nose due to allergen exposure and is characterized by sneezing, nasal congestion, itching of the nose, or postnasal discharge. Th... The primary aim is to assess the efficacy of Ayurvedic management for AR (or vataja pratishyaya) by comparing it to a conventional control group. The secondary aims are to determine the mean change in... This ongoing study is an open-label randomized controlled interventional trial, with a sample size of 90 both in the trial and standard control group (including dropouts, 20%), and will be carried out... As of May 2024, 72 patients have been enrolled in both groups. Data analysis should be completed by February 2025. The study will be reported following standard guidelines for reporting randomized con... The Ayurvedic approach could be an evidence-based therapeutic tactic for the management of AR.... Clinical Trials Registry India CTRI/2023/06/053395; https://tinyurl.com/564d2zz8.... DERR1-10.2196/56063....

Scandinavian trial of uncomplicated aortic dissection therapy: study protocol for a randomized controlled trial.

Contemporary management of uncomplicated type B aortic dissections (uTBAD) is based on the acuity and various morphological features. Medical therapy is mandatory, while the risks of early thoracic en... The trial is a randomized, open-label, superiority clinical trial with parallel assignment of subjects at 23 clinical sites in Denmark, Norway, Sweden, Finland, and Iceland. Eligibility includes patie... This trial will evaluate the primary question of whether early TEVAR improves survival at 5 years among uTBAD patients. Moreover, the costs and the impact on quality of life should provide sorely need... ClinicalTrials.gov NCT05215587. Registered on January 31, 2022....

Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial.

With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is often not add... The current study is a type 1 hybrid effectiveness-implementation trial to evaluate the impact of a proactive, opt-out tobacco treatment intervention on cessation outcomes and advance understanding of... This study will examine a novel approach to optimizing tobacco treatment delivery for PWH. Integrating effectiveness and implementation results will help define best practices for engaging PWH with ev... ClinicalTrials.gov: NCT05019495 (August 24, 2021)....

Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial.

Glaucoma is a chronic progressive optic neuropathy that necessitates lifelong treatment to reduce the decline of the optic nerve. Due to the extended and continuous treatments required for patients, c... The primary objective of this study is to conduct a single-center randomized control trial involving patients with glaucoma. Acupuncture will be evaluated as an adjunctive therapy. The trial aims to e... In this single-center randomized controlled trial, participants (N=50) with primary open-angle glaucoma will be randomly assigned to the treatment group, receiving ophthalmic acupuncture with "De Qi" ... Recruitment of participants for the trial commenced on June 28, 2023. A total of 10 participants have been enrolled to test the feasibility of the experiment. We anticipate that the preliminary data f... This trial uses rigorous methodology and comprehensive outcome measurements to assess the clinical efficacy of acupuncture as an adjunctive therapy for glaucoma, providing valuable insights for future... ClinicalTrials.gov NCT05753137; https://clinicaltrials.gov/study/NCT05753137.... DERR1-10.2196/57888....